Skip to Content

DROXIA 6336 DROXIA 6336 (Droxia 300 mg)

Generic Name: hydroxyurea

Pill imprint DROXIA 6336 DROXIA 6336 has been identified as Droxia 300 mg.

Droxia is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Droxia 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia 300 mg DROXIA 6336 DROXIA 6336
Droxia
Generic Name:
hydroxyurea
Imprint:
DROXIA 6336 DROXIA 6336
Strength:
300 mg
Color:
Purple
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antimetabolites
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00003-6336
Inactive Ingredients:
citric acid monohydrate
gelatin
lactose
magnesium stearate
sodium phosphate
titanium dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide